SAN SEBASTIÁN/BARCELONA, November 20, 2024 – We are proud to announce the publication of our first Environmental, Social, and Governance (ESG) report, a milestone that reflects our deep commitment to responsible and sustainable investment. This report underscores our mission to improve patients’ lives and create a positive societal impact by funding the development of transformative therapies.

This ESG report highlights the journey that began in 2015 when we became signatories of the UNPRI, embedding ESG principles into our core investment strategy. Nearly a decade later, these values are fully integrated into our processes, shaping how we support scientific progress and create long-term value.

Looking ahead, we aim to further refine our ESG methodologies, deepen our engagement with portfolio companies, and champion diversity and inclusion at all levels.

Our commitment to ESG remains at the heart of our efforts to deliver meaningful impact and adapt to evolving global challenges.

Dive into our full ESG report and join us on this transformative journey.